Search
On May 31, 2023, W. Matthew Bryant presented on “Land Surveying Law and Regulation” as part of a continuing education presentation on Illinois Land Surveying Law and Ethics. Topics addressed included: Land Surveyor business formation; professional Land Surveyor regulatory requirements; the related...
Richard "Shark" Forsten will present on the coming New Castle County county-wide property tax reassessment during a live seminar.
Saul Ewing is a proud sponsor of the M&A East Conference held by the Philadelphia Chapter of the Association of Corporate Growth. M&A East attracts top strategic and financial dealmakers as well as leading middle market advisors and provides an environment for valuable networking. The conference...
Developers Secure $83 Million Construction Loan For 25-Story Mixed-Use Project In Downtown Hollywood Attorneys Luis Flores and Michael Denberg of Saul Ewing represented the developer in closing the transaction. “We are proud to be part of a development team that is focused on bringing new life to...
BTI and Bridge Investment Nab $83M For Downtown Hollywood Rental BY JULIA ECHIKSON BTI Partners and Bridge Investment Group secured $83 million for a rental project on the site of the former Bread Building in Downtown Hollywood, Fla. — part of a $500 million mixed-use development — the developers...
Forest Development and RPC Land $270M For Luxury Condo Near West Palm BY JULIA ECHIKSON Forest Development and Dan Kodsi’s Royal Palm Companies scored one of South Florida’s largest construction loans this year, $269 million, for a luxury condo project north of West Palm Beach, Fla. The waterfront...
$269 Million Construction Loan for South Florida Mixed-Use Project Is Among Largest of Its Kind “This transaction underlines the strength of Peter [Baytarian]’s vision and the importance of the Nautilus 220 project to the area,” said Anthony Kang, a partner with Saul Ewing.
Washington, D.C., November 24, 2021 – Saul Ewing LLP served as counsel to Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) in the successful completion today of its previously announced $450 million acquisition of Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS). The acquisition strengthens Supernus'...